IMC Chicago’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.31M Sell
77,200
-5,400
-7% -$232K ﹤0.01% 2146
2025
Q4
$3.62M Buy
82,600
+25,200
+44% +$1.04M ﹤0.01% 1967
2025
Q3
$2.37M Buy
57,400
+10,600
+23% +$426K ﹤0.01% 2102
2025
Q2
$2.06M Buy
46,800
+8,000
+21% +$320K ﹤0.01% 1982
2025
Q1
$1.43M Buy
+38,800
New +$1.38M ﹤0.01% 2024
2024
Q1
Sell
-10,800
Closed -$259K 2390
2023
Q4
$259K Buy
+10,800
New +$235K ﹤0.01% 1763

Other funds holding EXEL

IMC Chicago's EXEL Position: Q1 2026 in Review

IMC Chicago opened a new position in Exelixis (EXEL) in Q1 2026: 9,170 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #4290 among its holdings. This is a return to the name: IMC Chicago previously reported a position in EXEL as recently as Q4 2023.

IMC Chicago first reported a position in EXEL in Q4 2023 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • IMC Chicago held 9,170 shares of Exelixis worth $393K as of Q1 2026.
  • Exelixis was a new IMC Chicago position in Q1 2026.
  • Exelixis made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4290 holding.
  • IMC Chicago first reported a position in Exelixis in Q4 2023 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.